DOCSLIB.ORG

Diagnostics for Latent TB Infection Subgroup

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Diagnostics for Latent TB Infection Subgroup Diagnostics for Latent TB Infection Subgroup Surname First name Institution Country Abubakar Ibrahim Centre for Infections UK Adetifa Ifedayo Medical Research Council (UK) Labs. The Gambia Aggerbeck Henrik Statens Serum Institut Denmark Ahmed Shwikar Alexandria University Egypt Albalak Rachel CDC USA Amlerova Jana University Hospital, Inst. Of Microbiology Czech Republic Banach David Mount Sinai Medical Center USA Banaei Niaz Stanford Univ. School of Medicine USA Bishai David Johns Hopkins Bloomberg School of Public Health USA Bourgarit Anne INSERM/ Assistance publique dept. France Caamal Ley Angel Reg. Research Center 'Dr. Hideyo Noguchi' Mexico Cardona Pere-Joan Inst. Investigacio en Ciencies de la Salut Spain Carnicer-Pont Dolors Public Health Agency Barcelona Spain Chandrasekaran Sujatha Global Hospitals & Health City India Chapman Ann L.N. Royal Hallamshire Hospital UK Chegou Novel N South Africa Chuanyou Li Beijing TB & Thor.Tumor Res. Inst. China Cirillo Daniela Maria San Raffaele Scientific Institute Italy Davidow Amy University of Med & Dent New Jersey USA Dheda Keertan University of Cape Town South Africa Diel Roland Public Health Department Germany Dilektaşlı Aslı Görek Baskent University School of Med. Turkey Doherty T. Mark Statens Serum Institute Denmark Domínguez Jose Int. d'Investigacio en Ciencies de la Salut Spain Duarte Raquel Pneumologic Diagnosis Centre Portugal El-khushman Haytham King Hussein Med. Center Jordan Elliott Julian Macfarlane Burnet Institute Australia Ellis Edward TB Prevention & Control, PH Agency of Canada Canada Emmerson Jonathan Otsuka Novel Products GmbH Germany Ferrara Giovanni University of Perugia Italy Gaines Hans Swedish Inst. For Infect. Disease Control Sweden Garcia Jose Maria Hospital San Agustin Spain Garcia Luis F Universidad de Antioquia Colombia Geluk Annemieke Leiden University Med. Centre The Netherlands Gonzalez Alberto Vargas Regional Research Ctr. 'Dr. Hideyo Noquchi' Mexico Goujon Catherine Centre Hospitalier Lyon Sud France Granger Chris Oxford Immunotec UK Graviss Edward A. Methodist Hospital Research Inst. USA Grewal Harleen University of Bergen Norway Hill Philip University of Otago School of Med. New Zealand Ivanyi Juraj Kings College London UK Jiménez-Delgadillo Bertha Universidad Autonoma de Yucatan Mexico Källenius Gunilla Karolinska Institutet Sweden Keane Joseph St. James' Hospital Ireland Khazaei Soheila Min. of Health and Medical Edu. Iran Kowada Akiko Bunkyo City Public Health Center Japan Kruczak Katarzyna Jagiellonian Univ. School of Medicine Poland Laniado-Laborin Rafael Hospital General de Tijuana Mexico Lee Hyejon Korean Institute of Tuberculosis Republic of Korea Leung Chi Chiu Tuberculosis and Chest Service China Lewinsohn Deborah Oregon Healthy and Science University USA Lobue Philip CDC USA Locht Camille Institut Pasteur de Lille France Losi Monica Univ. of Modena and Reggio Emilia Italy Madhina Denford Habitat for Humanity South Africa Maistry Nattele CSIR South Africa Mandalakas Anna Case Western Reserve University USA Markova Roumiana Nat. Centre of Infectious and Parasitic Diseases Bulgaria Markova Nadya Dimitrova Bulgarian Academy of Science Bulgaria Mascart Françoise Universite Libre de Bruxelles Belgium Menzies Richard McGill University Canada Micha Roumiantzeff Roumiantzeff Consultant TB VAC France Mutimutema Monalisa University of Zimbabwe - UCSF Programme Zimbabwe Narasimhan Padmanesan Australia Nienhaus Albert Accident Insurance & Prev. in Health & Welfare Serv. Germany Osborne Jill Fio Corporation Canada Ottenhoff Tom HM Leids Universitair Med. Centrum The Netherlands Parida Dr Shreemanta K Max Planck Inst. For Infection Biology Germany Peng Tao Chinese Academy of Sciences China Rathe Chris PriTest Inc. USA Ravn Pernille University Hospital Herlev Denmark Reves Randall University of Colorado HSC USA Richeldi Luca Univ. of Modena & Reggio Emilia Italy Ringhausen Felix C. Spital Bulach Switzerland Roberts Teri University of Cape Town South Africa Rodriguez-De Marco Jorge National TB Control Program Uruguay Rohde Gernot University Hospital Bergmannsheil Germany Rothel Jim Cellestis Ltd Australia Ruhwald Morten Copenhagen University Hospital Denmark Schraufnagel Dean E. University of Illinois at Chicago USA Sechi Leonardo A. University of Sassari Italy Sester Martina University of Saarland Germany Sethi Sunil PGIMER India Shanaube Kwame Zambart Project Zambia Singh Jay Praksash Narayan Supra Nat. TB Reference Lab. Oman Sismanidis Charalampos (Babis) World Health Organization Switzerland Soborg Dr Bolette Statens Serum Institut Denmark Surucuoglu Suheyla Celal Bayar University Turkey Svobodova Jana Health Institute In Brno Czech Republic Talat Najeeha Aga Khan University Hospital Pakistan Tebruegge Dr Marc University of Melbourne, Murdoch Children's Inst. Australia Tierney Dylan Massachusetts General Hospital USA Trajman Anete Gama Filho University Brasil Trnka Ludek National TB Surveillance Unit Czech Republic Tuuminen Tamara Haartman Inst., Univ. of Helsinki Finland Upadhye Vijay Jagdish Mahatma Gandhi Inst. Of Med. Sciences India Vargas-Kasambira Tafadzwa Stephen US Food and Drug Administration USA Wagner Dirk University of Freiburg Germany Walzl Gerhard Stellenbosch University South Africa Whalen Christine Health Bridge Consulting Int. The Netherlands Wilkinson Robert J University of Cape Town South Africa Wilkinson Katalin Andrea University of Cape Town South Africa Wolf Timo Hospital of Goethe University Germany Yanai Hideki Japan Anti-tuberculosis Association Japan Yim Jae-Joon Dept. of Internal Med. And Lung Inst. Republic of Korea Zellweger Jean-Pierre Swiss Lung Association Switzerland Zhang Whenhong Fudan University China Zumla Ali University College London UK Zwerling Alice McGill University Canada .
Load more

Recommended publications
  • A Historical Look at Technology and Society in Japan (1500-1900)
    A Historical Look at Technology and Society in Japan (1500-1900) An essay based on a talk given by Dr. Eiichi Maruyama at the PART 1 Japan-Sweden Science Club (JSSC) annual meeting, Tokyo, 31 Gunpowder and Biotechnology October 1997. - Ukiyo-e and Microlithography Dr. Maruyama studied science history, scientific philosophy, and phys- In many parts of the world, and Japan was no exception, the 16th ics at the University of Tokyo. After graduating in 1959, he joined Century was a time of conflict and violence. In Japan, a number of Hitachi Ltd., and became director of the company’s advanced re- feudal lords were embroiled in fierce battles for survival. The battles search laboratory in 1985. He was director of the Angstrom Tech- produced three victors who attempted, one after another, to unify nology Partnership, and is currently a professor at the National Japan. The last of these was Ieyasu Tokugawa, who founded a “per- Graduate Institute for Policy Studies. manent” government which lasted for two and a half centuries before it was overthrown and replaced by the Meiji Government in Introduction 1868. Japanese industry today produces many technically advanced prod- ucts of high quality. There may be a tendency to think that Japan One particularly well documented battle was the Battle of Nagashino has only recently set foot on the technological stage, but there are in 1575. This was a showdown between the organized gunmen of numerous records of highly innovative ideas as far back as the 16th the Oda-Tokugawa Allies (two of the three unifiers) and the in- century that have helped to lay the foundations for the technologi- trepid cavalry of Takeda, who was the most formidable barrier to cal prowess of modern day Japan.
    [Show full text]
  • Syphilis - Its Early History and Treatment Until Penicillin, and the Debate on Its Origins
    History Syphilis - Its Early History and Treatment Until Penicillin, and the Debate on its Origins John Frith, RFD Introduction well as other factors such as education, prophylaxis, training of health personnel and adequate and rapid “If I were asked which is the most access to treatment. destructive of all diseases I should unhesitatingly reply, it is that which Up until the early 20th century it was believed that for some years has been raging with syphilis had been brought from America and the New impunity ... What contagion does World to the Old World by Christopher Columbus in thus invade the whole body, so much 1493. In 1934 a new hypothesis was put forward, resist medical art, becomes inoculated that syphilis had previously existed in the Old World so readily, and so cruelly tortures the before Columbus. I In the 1980’s palaeopathological patient ?” Desiderius Erasmus, 1520.1 studies found possible evidence that supported this hypothesis and that syphilis was an old treponeal In 1495 an epidemic of a new and terrible disease broke disease which in the late 15th century had suddenly out among the soldiers of Charles VIII of France when evolved to become different and more virulent. Some he invaded Naples in the first of the Italian Wars, and recent studies however have indicated that this is not its subsequent impact on the peoples of Europe was the case and it still may be a new epidemic venereal devastating – this was syphilis, or grande verole, the disease introduced by Columbus from America. “great pox”. Although it didn’t have the horrendous mortality of the bubonic plague, its symptoms were The first epidemic of the ‘Disease of Naples’ or the painful and repulsive – the appearance of genital ‘French disease’ in Naples 1495 sores, followed by foul abscesses and ulcers over the rest of the body and severe pains.
    [Show full text]
  • Hideyo Noguchi (1876-1928): Distinguished Bacteriologist
    Singapore Med J 2014; 55(10): 550-551 Medicine in Stamps doi: 10.11622/smedj.2014140 Hideyo Noguchi (1876-1928): Distinguished bacteriologist Siang Yong Tan1, MD, JD, Jill Furubayashi2 ideyo Noguchi overcame significant adversity to won a fellowship to study with Thorvald Madsen in Copenhagen, become a physician-scientist – a humble origin and a and upon his return a year later, joined the newly established Hcrippling childhood injury render his achievements all Rockefeller Institute for Medical Research (RIMR). It turned out the more extraordinary. In typical fashion, Noguchi attributed that its director was Flexner, his old mentor, and it was there his success to pure diligence, saying, “There is no such thing as that Noguchi launched his career in infectious disease research. genius […] to work three, four, five times harder than anyone else, that is genius.” SYPHILIS In 1909, Noguchi published an extensive monograph, Snake Venoms: An Investigation of Venomous Snakes EARLY CAREER Born Seisaku Noguchi on November 24, with Special Reference to the Phenomena of Their Venoms, 1876, to impoverished, illiterate farmers in Inawashiro, Fukushima which established his reputation as a serious and productive prefecture, Japan, Noguchi as toddler fell into a hearth, sustaining scientist and secured his position at RIMR. There he stayed for burns to the left side of his body that left him with a permanently the rest of his career, publishing over 200 papers on a range of disfigured hand with fused fingers. However, this disability did infectious diseases as diverse as syphilis, tuberculosis, trachoma, not detract from Noguchi’s enthusiasm and hard work, catching poliomyelitis, rabies, verruga peruviana, yellow fever, Rocky the attention of a school principal, Sakae Kobayashi, who Mountain spotted fever and Oroya fever.
    [Show full text]
  • Ceremony for Hideyo Noguchi
    （21 ） [ English Edition ］ 週刊 NY 生活 SHUKAN NEW YORK SEIKATSU 2019 年（令和元年） 6月8日 （土） VOICES From America and professor at the Icahn THE NEW YORKERS School of Medicine at Mount Sinai, also read messages from President The Princess, Yasuo Yago of the Hideyo Noguchi the Tea and Me TH E Memorial Society about Dr. JAPAN VOICE Noguchi’s birthplace Inawashiro, Kia Cheleen Fukushima, both in Japanese and in Japan COOL JAPAN from New Yorkers’ Viewpoints English. At the end, Representative recently Mitch Rose of the Woodlawn crowned a new Cemetery gave the closing address. Emperor and Rockefeller University since 2018 to Flowers were sent from 10 orga - Empress, find a way to control the develop - nizations: The Japanese Medical marking the ment of the disease. Coming to Society of America, The Consulate “Reiwa” era. I America at the age of 24 and resem - General of Japan in New York, The have actually bling Dr. Noguchi who devoted his Rockefeller University, The Japanese interacted with Empress Masako, then life to science for humanity at the American Association of New York, Princess Masako, on several occa - risk of his own, he is praised to be The Nippon Club, The New York sions during my tenure at the United the perfect person for inheriting Japanese-American Lions Club, the Nations in Tokyo. Hideyo Noguchi’s teachings and Japanese Medical Support Network in When (then-) Princess Masako ambitions. New York, the New York Fukushima- started coming to the United Nations Robert Yanagisawa, President Kenjinkai, the Woodlawn Cemetery building, we felt very honored to be in of The Japanese Medical Society of and The New York Hideyo Noguchi her presence.
    [Show full text]
  • Dr. Simon Flexner] M
    Rockefeller University Digital Commons @ RU Rockefeller University Research Profiles Campus Publications Summer 1987 Dr. Flexner's Experiment: [Dr. Simon Flexner] M. S. Kaplan Follow this and additional works at: http://digitalcommons.rockefeller.edu/research_profiles Part of the Life Sciences Commons Recommended Citation Kaplan, M. S., "Dr. Flexner's Experiment: [Dr. Simon Flexner]" (1987). Rockefeller University Research Profiles. Book 30. http://digitalcommons.rockefeller.edu/research_profiles/30 This Article is brought to you for free and open access by the Campus Publications at Digital Commons @ RU. It has been accepted for inclusion in Rockefeller University Research Profiles by an authorized administrator of Digital Commons @ RU. For more information, please contact [email protected]. THE ROCKEFELLER UNIVERSITY What is now proved RESEARCH was once only imagin'd -WILLIAM BLAKE PROFILES SUMMER 1987 Dr. Flexner's Experiment Simon Plexner, 1863-1946 When Simon Flexner retired in 1935 as the first director of The Rockefeller Institute for Medical Research, his colleagues wanted to organize a testimonial in his honor. But Flexner, in keeping with his characteristic reserve, politely declined. He had been director for thirty-three years, during which time the Institute had grown from a handful of scientists working in rented quarters to a world-renowned research center. As he passed through its gates for rhe last time,· he left behind, on its library shelves, the most durable and eloquent tribute to his career: one hundred
    [Show full text]
  • The Scientific Background of the International Sanitary Conferences
    The scientific background of the International Sanitary Conferences Norman Howard-Jones h 4 "1 Formerly Director, Division of Editorial and Reference Services, World Health Organization WORLD HEALTH ORGANIZATION GENEVA 1975 HISTORY OF INTERNATIONAL PUBLIC HEALTH, No. 1 This study originally appeared in WHO Chronicle, 1974, 28, 159-171, 229-247, 369-348, 414-426, 455-470, 495-508. 0 World Health Organization 1975 Publications of the World Health Organization enjoy copyright protection in accord- ance with provisions of Protocol 2 of the Universal Copyright Convention. For rights of reproduction or translation of WHO publications in part or in toto, application should be made to the Division of Publications and Translation, World Health Organization, Geneva, Switzerland. The World Health Organization welcomes such applications. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Director-General of the World Health Organization concerning the legal status of any country or territory or of its authorities, or concerning the delimitation of its frontiers. The author alone is responsible for the views expressed in this publication. l1 CONTENTS Page Preface ............................... 7 Introduction ............................. 9 The first conference : Paris. 1851 .................... 12 The second conference : Paris. 1859 .............. ..... 17 The third conference : Constantinople. 1866 ............... 23 The fourth conference : Vienna. 1874 .................. 35 The fifth conference : Washington. 188 1 ............ ..... 42 The sixth conference : Rome. 1885 .............. ..... 46 The seventh conference . Venice. 1892 ............. ..... 58 The eighth conference : Dresden. 1893 ............ ..... 66 The ninth conference : Paris. 1894 ................... 71 The tenth conference: Venice. 1897 .............. ..... 78 The eleventh conference : Paris. 1903 .................
    [Show full text]
  • Overview of Polio Outbreak Response in Kenya, 2013 to 2015
    Hideyo Noguchi African Prize Promoting Medical Research and Medical Service to Fight Infectious Diseases in the Africa Dr. Hideyo Noguchi - I shall not return to my native home if I do not achieve my objective Hideyo Noguchi (1876‒1928) was a prominent Japanese bacteriologist in the early twentieth century. In spite of a physical handicap, burn on his left hand during his early childhood, he managed to obtain, through extraordinarily hard work, a license to practice medicine in Japan. He moved to the United States in 1900 to work with Prof. Simon Flexner at the University of Pennsylvania and in 1904 joined the Rockefeller Institute for Medical Research (now Rockefeller University). He made important studies of snake venoms, of smallpox and yellow-fever vaccines, and of the laboratory diagnosis of trachoma. One of his most important achievements of this period was the successful cultivation of pure Syphilis Spirochaeta in 1911 which brought him to world prominence. After extensive travel throughout Central and South America researching on vaccines for such diseases as yellow fever, Oroya fever and poliomyelitis which threatened the lives of millions of people in those days, he eventually ventured into Africa to confirm his findings. He tried to demonstrate the hypothesis that yellow fever was caused by spirochete bacteria but in vain, because at that time the electron microscope to observe viruses had not been invented yet. While working in Accra, Ghana, he was struck down by the yellow fever virus, his last words being “I don’t understand.” The grave of Dr. Hideyo Noguchi in Woodlawn Cemetery in New York, the United States, is inscribed with the following epitaph: “Through devotion to science, he lived and died for humanity.” In 2004, Dr.
    [Show full text]
  • Hideyo Noguchi, 1916 the Rockefeller University
    Rockefeller University Digital Commons @ RU Harvey Society Lectures 1917 Hideyo Noguchi, 1916 The Rockefeller University Follow this and additional works at: http://digitalcommons.rockefeller.edu/harvey-lectures Recommended Citation The Rockefeller University, "Hideyo Noguchi, 1916" (1917). Harvey Society Lectures. 9. http://digitalcommons.rockefeller.edu/harvey-lectures/9 This Book is brought to you for free and open access by Digital Commons @ RU. It has been accepted for inclusion in Harvey Society Lectures by an authorized administrator of Digital Commons @ RU. For more information, please contact [email protected]. ".c,.;.,.;_/ ' SJ>IROCHJETES * DR. HIDEYO NOGUCHI The Rockefeller Institute for Medical Research 0-DAY a spirally shaped micro-organism may be called T either spirochreta, spirillum, treponenia, spironema, cristi­ spira or saprospira, according to the characteristics of· the organ­ ism. The choice of the generic name for a given variety is still very much dependent upon the indivi5lual views held by diffei"Bnt investigators, and this has led to a somewhat chaotic state of affairs in the nomenclatur� of this group of organisms. This is found to be the case more especially in the medical literature where these minute spiral organisms play an important part as causative agents of certain diseases. Nevertheless, thus far but little attention has been paid to the systematic position occupied by them. Since Ehren�erg 1 in 1838 introduced a new generic term "Spirochreta" to designate a free living spfral organism which he found in a swamp near Berlin, it remained practically unnoticed until 1904, when Schaudinn 2 stated as his view that certain spirochretes constitute a phase of the life cycle of trypanosomes; hence, that they are of protozoan origin instead of being plants.
    [Show full text]
  • Hideyo Noguchi Africa Prize
    48-52 Kurokawa:GF5 23/10/08 19:30 Page 48 Innovating for health and development Hideyo Noguchi Africa Prize Article by Kiyoshi Kurokawa (pictured), Chair, Hideyo Noguchi African Prize and PHOTO BY Special Advisor to the Cabinet of the Japanese Government with Tamaki Tsukada and Eri Maeda TETSUO SAKUMA n 28 May 2008 Brian Greenwood, of London School creation of wealth and social stability are some of the of Hygiene and Tropical Medicine, and Miriam Were requirements for us, the people of Africa, to get out of the Oof National AIDS Control Council of Kenya, were indignity in which most of us live. We, the people of awarded the First Hideyo Noguchi Africa Prize. Africa, believe that through this forum (TICAD) and The presentation ceremony hosted by Prime Minister Yasuo the prize outcomes will be positive for Africa”, Fukuda was attended by their Majesties the Emperor and (Miriam Were)2. Empress of Japan and hundreds of international dignitaries, The creation of the prize came out as a typical Koizumi- including more than 40 heads of state and government of the style coup de main during his visit to Africa in May 20063. It African countries participating in the Fourth Tokyo was literally a top-down initiative. Nobody at the time actually International Conference on African Development (TICAD IV). thought about the meaning, let alone the consequence, of The presentation ceremony marked the first day of the TICAD creating yet another prize in the already over-crowded IV held in Yokohama. The day happened to coincide with the international prize market.
    [Show full text]
  • Dr. Hideyo Noguchi's Academic Achievements and Contribution To
    Dr. Hideyo Noguchi’s Academic Achievements and Contribution to Africa 1. Dr. Hideyo Noguchi started his medical research in earnest after moving to the United States in 1901. As a leading researcher in the then fledgling Rockefeller Institute for Medical Research, Noguchi’s research paper output was extraordinary. The number of research papers written by Noguchi reached almost 200, and various kinds of infectious diseases came under his scope of research. Projects varied from investigation of pathogens and development of experimental technique, to immunology and production of vaccine which raised the academic profile of the Rockefeller Institute for Medical Research phenomenally worldwide. 2. Dr. Noguchi’s major research achievements are as follows: (1) Discovery of Treponema pallidum, the causative agent of syphilis, in the brains of progressive paralysis patients (1913) (2) Success in growing pure culture of syphilis spirochete (1911) (However, no one has succeeded ever since in the replication of pure culture of syphilis spirochete.) (3) Proves that both Oroya fever and verruga peruana are both caused by a single pathogen Bartonella bacilliformis by verifying that Bartonella bacilliformis invades red blood cells in both cases (1926) (4) Succeeds in isolating Leptospira icteroides from patients of yellow fever (1919) (Leptospira, which was then identified as the cause of yellow fever by Noguchi, was later disproved to be the spirochete of Weil’s Disease. His name is remembered in the binomial leptospira noguchi in the classification of spirochetes.) For the above academic achievements, Noguchi was three times nominated as a Nobel Prize candidate in the period 1914-1920. 3. Dr. Hideyo Noguchi was struck down by yellow fever while working in search of the pathogen of yellow fever in Accra, Ghana.
    [Show full text]
  • Neurosyphilis. Historical Perspectives on General Paresis of the Insane
    Central JSM Schizophrenia Bringing Excellence in Open Access Research Article *Corresponding author Jesper Vaczy Kragh, Department of Public Health , CoRe, University of Copenagen, Karen Blxens Plads 8, Neurosyphilis. Historical DK-2300, Denmark, Tel: 45 29792902; Email: Submitted: 15 September 2017 Perspectives on General Paresis Accepted: 19 September 2017 Published: 23 September 2017 of the Insane Copyright © 2017 Kragh Jesper Vaczy Kragh* Department of Public Health, University of Copenhagen, Denmark OPEN ACCESS Keywords Abstract • Neurosyphilis In the early nineteenth century general paresis of the insane (GPI), also known as general • General paresis paralysis or dementia paralytica, was described as a new psychiatric disorder. It soon became • Penicillin one of the most dreaded mental disorders. Large numbers of patients with GPI were admitted • Malaria fever therapy to mental hospitals in the nineteenth and early twentieth century. The inevitable outcome of • History of psychiatry the disease was death within a short period of time. The cause of GPI was unknown until the late nineteenth century, and there was no effective treatment. The development of accurate diagnostic methods was introduced in the early twentieth century, and it was confirmed that GPI is a syphilitic disease. New effective treatment options eventually made GPI a rare diagnosis in psychiatry. Nowadays, GPI is an uncommon disease, but the history of the disorder and its treatment offers important historical lessons. ABBREVIATIONS GPI: General Paresis of the Insane; AR Pupil: Argyll Robertson Pupil also studied GPI in the early nineteenth century, noting the fatal course of the disease and the increasing number of cases of GPI [2]. GENERAL PARESIS OF THE INSANE Esquirol reported that one-sixth of all admissions to Charenton in 1828 were paralytic patients, and the disease was also common Napeoleonic Wars [1-3].
    [Show full text]
  • Pure Cultivation in Vivo of Vaccine Virus Free from Bacteria.*
    PURE CULTIVATION IN VIVO OF VACCINE VIRUS FREE FROM BACTERIA.* BY HIDEYO NOGUCHI, M.D. (From the Laboratories of The Rockefeller Institute for Medical Research.) Downloaded from http://rupress.org/jem/article-pdf/21/6/539/1138538/539.pdf by guest on 03 October 2021 PLATES 39 TO 5~ In spite of much effort n,o method has, up to the present time, been perfected by which vaccine virus can be propagated in a pure state, free from con'taminating bacteria. The method of propagating vac- cine virus universally practiced today consists in transmitting the virus from the skin of one calf to that of ano~ther. Although the inoculation of the virus is carried out under precautions as strtictly aseptic as possible, the fresh product nevertheless yielded by the skin contains a not inconsiderable number of different bacteria de- rived from the skin surfaces, the air, etc. The employment of glycerin as an elective germicide against the non-spore-bearing bacteria contained in fresh, or so called "green," vaccine pulp results in a great reducti'on both in number and variety of the contaminating micro6rganisms, without at the same time seriously impairing the activity of the vaccine virus (I). After con- tact with concentrated glycerin, in a refrigerator, ranging from one to three months, the virus usually is freed from most of the bacteria and becomes "ripe " for practical use in vaccina,tion on human beings. Different samples of the ripe vaccine preparations, as issued from various authorized sources, vary in their activities as well as in their germ contents.
    [Show full text]